Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 107

1.

A phase II trial of carboplatin for intraocular retinoblastoma.

Dunkel IJ, Lee TC, Shi W, Beaverson KL, Novetsky D, Lyden D, Finlay JL, McCormick B, Abramson DH.

Pediatr Blood Cancer. 2007 Oct 15;49(5):643-8.

PMID:
17301956
2.

Chemoreduction plus focal therapy for retinoblastoma: factors predictive of need for treatment with external beam radiotherapy or enucleation.

Shields CL, Honavar SG, Meadows AT, Shields JA, Demirci H, Singh A, Friedman DL, Naduvilath TJ.

Am J Ophthalmol. 2002 May;133(5):657-64.

PMID:
11992863
3.

Role of chemotherapy alone or in combination with hyperthermia in the primary treatment of intraocular retinoblastoma: preliminary results.

Levy C, Doz F, Quintana E, Pacquement H, Michon J, Schlienger P, Validire P, Asselain B, Desjardins L, Zucker JM.

Br J Ophthalmol. 1998 Oct;82(10):1154-8.

4.

Combined chemotherapy and local treatment in the management of intraocular retinoblastoma.

Brichard B, De Bruycker JJ, De Potter P, Neven B, Vermylen C, Cornu G.

Med Pediatr Oncol. 2002 Jun;38(6):411-5.

PMID:
11984802
5.

Macular retinoblastoma: evaluation of tumor control, local complications, and visual outcomes for eyes treated with chemotherapy and repetitive foveal laser ablation.

Schefler AC, Cicciarelli N, Feuer W, Toledano S, Murray TG.

Ophthalmology. 2007 Jan;114(1):162-9. Epub 2006 Oct 27.

PMID:
17070578
6.

Causes of chemoreduction failure in retinoblastoma and analysis of associated factors leading to eventual treatment with external beam radiotherapy and enucleation.

Gündüz K, Günalp I, Yalçindağ N, Unal E, Taçyildiz N, Erden E, Geyik PO.

Ophthalmology. 2004 Oct;111(10):1917-24.

PMID:
15465557
7.

Superselective ophthalmic artery chemotherapy as primary treatment for retinoblastoma (chemosurgery).

Abramson DH, Dunkel IJ, Brodie SE, Marr B, Gobin YP.

Ophthalmology. 2010 Aug;117(8):1623-9. doi: 10.1016/j.ophtha.2009.12.030. Epub 2010 Apr 9.

PMID:
20381868
8.

Outcomes of a two-drug chemotherapy regimen for intraocular retinoblastoma.

Zage PE, Reitman AJ, Seshadri R, Weinstein JL, Mets MB, Zeid JL, Greenwald MJ, Strauss LC, Goldman S.

Pediatr Blood Cancer. 2008 Mar;50(3):567-72.

PMID:
17729249
9.

The success of primary chemotherapy for group D heritable retinoblastoma.

Cohen VM, Kingston J, Hungerford JL.

Br J Ophthalmol. 2009 Jul;93(7):887-90. doi: 10.1136/bjo.2008.142679. Epub 2008 Aug 14.

PMID:
18703556
10.

A phase I/II study of subconjunctival carboplatin for intraocular retinoblastoma.

Abramson DH, Frank CM, Dunkel IJ.

Ophthalmology. 1999 Oct;106(10):1947-50.

PMID:
10519590
11.

Conservative treatments of intraocular retinoblastoma.

Lumbroso-Le Rouic L, Aerts I, Lévy-Gabriel C, Dendale R, Sastre X, Esteve M, Asselain B, Bours D, Doz F, Desjardins L.

Ophthalmology. 2008 Aug;115(8):1405-10, 1410.e1-2. doi: 10.1016/j.ophtha.2007.11.009. Epub 2008 Jan 25.

PMID:
18222001
12.

Second malignant neoplasms following chemoreduction with carboplatin, etoposide, and vincristine in 245 patients with intraocular retinoblastoma.

Turaka K, Shields CL, Meadows AT, Leahey A.

Pediatr Blood Cancer. 2012 Jul 15;59(1):121-5. doi: 10.1002/pbc.23278. Epub 2011 Aug 8.

PMID:
21826785
13.

Socioeconomic impact of modern multidisciplinary management of retinoblastoma.

Wilson MW, Haik BG, Rodriguez-Galindo C.

Pediatrics. 2006 Aug;118(2):e331-6.

PMID:
16882777
14.

Effect on ocular survival of adding early intensive focal treatments to a two-drug chemotherapy regimen in patients with retinoblastoma.

Wilson MW, Haik BG, Liu T, Merchant TE, Rodriguez-Galindo C.

Am J Ophthalmol. 2005 Sep;140(3):397-406.

PMID:
16138999
16.

Treatment of intraocular retinoblastoma with vincristine and carboplatin.

Rodriguez-Galindo C, Wilson MW, Haik BG, Merchant TE, Billups CA, Shah N, Cain A, Langston J, Lipson M, Kun LE, Pratt CB.

J Clin Oncol. 2003 May 15;21(10):2019-25.

PMID:
12743157
17.

Chemothermotherapy in the management of retinoblastoma.

Lumbroso L, Doz F, Urbieta M, Levy C, Bours D, Asselain B, Vedrenne J, Zucker JM, Desjardins L.

Ophthalmology. 2002 Jun;109(6):1130-6.

PMID:
12045055
18.

Survival in extra-orbital metastatic retinoblastoma:treatment results.

Leal-Leal CA, Rivera-Luna R, Flores-Rojo M, Juárez-Echenique JC, Ordaz JC, Amador-Zarco J.

Clin Transl Oncol. 2006 Jan;8(1):39-44. Review.

PMID:
16632438
19.

Treatment of retinoblastoma patients with chemoreduction plus local therapy: experience of the AC Camargo Hospital, Brazil.

Antoneli CB, Ribeiro KC, Steinhorst F, Novaes PE, Chojniak MM, Malogolowkin M.

J Pediatr Hematol Oncol. 2006 Jun;28(6):342-5.

PMID:
16794500
20.

Experience with chemoreduction and focal therapy for intraocular retinoblastoma in a developing country.

Chantada GL, Fandiño AC, Raslawski EC, Manzitti J, de Dávila MT, Casak SJ, Scopinaro MJ, Schvartzman E.

Pediatr Blood Cancer. 2005 May;44(5):455-60.

PMID:
15558702

Supplemental Content

Support Center